School of Research
During the SLS summer school students usually expect to gain wet lab experience and benefit from working alongside PhD students and postdoctoral researchers on the bench. The coronavirus pandemic has had a major impact on this year’s programme as access to the labs was restricted and placements cancelled. Instead, twenty Dundee undergraduates from second and third year undertook virtual projects over a period of five weeks.
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
Since the end of June, our researchers have been returning to the School of Life Sciences to restart their lab-based research. This work encompasses a diverse range of topics from microbiology to gene regulation and plant sciences to drug discovery. Alongside this, scientists are continuing to contribute to the worldwide efforts to tackle COVID-19. Some projects are progressing while others are just starting up following recent funding awards. What is it like as a scientist working with social distancing and additional measures in place in the research laboratories?
Scientists at the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee have been awarded £4.9million in follow-on funding from the Wellcome Trust, boosting their efforts to understand more about potential drugs that could be used to treat neglected tropical diseases (NTDs) and other parasitic diseases.
Protein levels in human cells can determine the susceptibility of people to diseases such as ovarian cancer and Alzheimer’s, a University of Dundee study has found.
Human cell proteins are the targets of almost all drugs and differences in protein activity or the levels of proteins present are ultimately responsible for many different types of disease.
- CARE (Corona Accelerated R&D in Europe) is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for Covid-19
- The initiative is committed to a long-term understanding of the disease and development of therapies for Covid-19 and future coronavirus threats in addition to urgent efforts to repurpose existing therapies for a potential immediate response
Natalie Bamford, a Postdoctoral Research Assistant in the lab of Nicola Stanley-Wall, has been awarded a prestigious two-year EMBO Long-term fellowship to study bacterial biofilms which will help efforts to remove biofilms when they are detrimental or, conversely, aid in the exploitation of biofilms for industrial biotechnology.
Three of the world’s leading pharmaceutical companies have pledged £7.5 million to allow the University of Dundee’s Division of Signal Transduction Therapy (DSTT) to continue its award-winning work.
Pharmaceutical giants Boehringer Ingelheim, GlaxoSmithKline and Merck KGaA, Darmstadt, Germany, will provide the multi-million pound support for fundamental research in multiple therapeutic areas, including cancer, arthritis, lupus, hypertension and Parkinson’s disease. This new round of funding will support dozens of posts at Dundee for the next four years.
A research team led by the University of Dundee’s Dr Satpal Virdee has identified a potential new strategy for treating a range of neurodegenerative diseases and neurological disorders for which there are limited treatments.